Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 102 Carcinoma, Non-Small-Cell Lung 93 Multiple Myeloma 80 Prostatic Neoplasms 74 Colorectal Neoplasms 59 Neoplasms 57 Leukemia, Myeloid, Acute 56 Lymphoma 48 Squamous Cell Carcinoma of Head and Neck 43 Lung Neoplasms 39 Ovarian Neoplasms 38 Melanoma 38 Neoplasm Metastasis 36 Pancreatic Neoplasms 35 Lymphoma, Non-Hodgkin 35 Carcinoma, Hepatocellular 34 Lymphoma, Large B-Cell, Diffuse 33 Sarcoma 31 Head and Neck Neoplasms 31 Urinary Bladder Neoplasms 30 Precursor Cell Lymphoblastic Leukemia-Lymphoma 29 Carcinoma, Renal Cell 29 Leukemia, Lymphocytic, Chronic, B-Cell 28 Hodgkin Disease 28 Endometrial Neoplasms 28 Triple Negative Breast Neoplasms 27 Myelodysplastic Syndromes 26 Recurrence 25 Hematologic Neoplasms 25 Glioma 25

Interventions

ribociclib 1 Letrozole 1 Goserelin 1 Chemotherapy, Adjuvant 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × HER2 Negative Breast Cancer × 30 days × Clear all

NCT06953882 2026-05-26

SELECT

Yale University

Phase 2 Recruiting

HER2 Negative Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡